Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EVGN

Evogene Ltd

Apr 15 • 01:58PM ET

0.8331

+0.0131 1.60 %

Healthcare • Biotechnology • Israel • NASD

Peers: INO OCGN MRKR QURE DTIL IBRX CRIS IBIO AQST HOOK

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.16	Insider Own	0.96%	Shs Outstand	8.72M	Perf Week	3.72%
Market Cap	10.09M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	0.00%	Shs Float	8.63M	Perf Month	5.30%
Enterprise Value	11.36M	PEG	-	EPS next Q	-0.27	Inst Own	3.02%	Short Float	2.77%	Perf Quarter	-19.12%
Income	-8.48M	P/S	2.55	EPS this Y	-39.20%	Inst Trans	0.45%	Short Ratio	0.49	Perf Half Y	-34.91%
Sales	3.95M	P/B	-	EPS next Y	46.67%	ROA	-50.88%	Short Interest	0.24M	Perf YTD	-24.26%
Book/sh	-0.01	P/C	0.78	EPS next 5Y	20.08%	ROE	-655.00%	52W High	2.42 -65.57%	Perf Year	-16.27%
Cash/sh	1.07	P/FCF	-	EPS past 3/5Y	44.96% 33.52%	ROIC	-606.00%	52W Low	0.72 15.71%	Perf 3Y	-85.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	32.01% 29.94%	Gross Margin	13.40%	Volatility	6.64% 8.46%	Perf 5Y	-98.04%
Dividend TTM	-	EV/Sales	2.88	EPS Y/Y TTM	62.24%	Oper. Margin	-381.79%	ATR (14)	0.06	Perf 10Y	-98.80%
Dividend Ex-Date	-	Quick Ratio	4.32	Sales Y/Y TTM	-53.54%	Profit Margin	-214.57%	RSI (14)	50.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.38	EPS Q/Q	-1069.75%	SMA20	1.30%	Beta	1.46	Target Price	2.25
Payout	-	Debt/Eq	-	Sales Q/Q	-80.51%	SMA50	-3.91%	Rel Volume	0.07	Prev Close	0.82
Employees	52	LT Debt/Eq	-	Earnings	Mar 05 BMO	SMA200	-25.18%	Avg Volume	484.12K	Price	0.83
IPO	Mar 05, 2008	Option/Short	No / Yes	EPS/Sales Surpr.	-134.23% 14.18%	Trades		Volume	23,577	Change	1.60%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-21	Initiated	ROTH Capital	Buy	$7
Jul-29-21	Initiated	Aegis Capital	Buy	$10
Dec-01-20	Initiated	Cantor Fitzgerald	Overweight	$9
Dec-16-13	Initiated	Oppenheimer	Outperform	$26

Apr-02-26 04:01PM	Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
Mar-31-26 08:00AM	Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock (PR Newswire)
Mar-13-26 09:01PM	Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline (GuruFocus.com)
Mar-09-26 09:00AM	Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 (PR Newswire)
Mar-06-26 08:30AM	Evogene Ltd. Q4 2025 Earnings Call Summary (Moby)
07:32AM	Loading…
Mar-05-26 07:32AM	Evogene: Q4 Earnings Snapshot (Associated Press Finance) -6.16%
07:00AM	Evogene Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
Feb-25-26 08:00AM	Evogene Releases CEO Letter to Shareholders (PR Newswire)
Feb-19-26 08:00AM	Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release (PR Newswire) -5.57%
Feb-18-26 06:17AM	Evogene and QUT partner on AI-based cancer therapies (Pharmaceutical Business Review)
Feb-17-26 08:00AM	Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics (PR Newswire)
Feb-11-26 08:00AM	Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases (PR Newswire)
Feb-10-26 01:20PM	Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds (PR Newswire) -7.34%
08:00AM	Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI (PR Newswire)
Feb-09-26 08:00AM	Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board (PR Newswire)
08:00AM	Loading…
Feb-04-26 08:00AM	Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer (PR Newswire)
Jan-07-26 07:00AM	Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders (PR Newswire)
Dec-30-25 07:00AM	Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development (PR Newswire)
Nov-20-25 07:00AM	Evogene Reports Third Quarter 2025 Financial Results (PR Newswire) -7.69%
Nov-11-25 07:00AM	Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming (PR Newswire)
Nov-06-25 09:00AM	Evogene Schedules Third Quarter 2025 Financial Results Release (PR Newswire)
Aug-28-25 07:00AM	Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York (PR Newswire)
Aug-20-25 03:05AM	Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... (GuruFocus.com)
Aug-19-25 07:10AM	Evogene: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Evogene Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-12-25 07:00AM	Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases (PR Newswire)
Jul-29-25 07:00AM	Evogene Schedules Second Quarter 2025 Financial Results Release (PR Newswire)
Jul-08-25 07:00AM	Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) +6.82%
Jun-10-25 07:00AM	Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud (PR Newswire) +100.00%
May-22-25 01:21AM	EverGen Infrastructure Corp. Announces Closing of First Tranche of Private Placement and Change of Management (GlobeNewswire)
07:00AM	Loading…
May-21-25 07:00AM	Evogene Reports First Quarter 2025 Financial Results (PR Newswire) -6.69%
May-14-25 08:37PM	EverGen Infrastructure Corp. Announces Receipt of TSX Venture Exchange Final Approval of Real Property Sale and Update to Previously Announced Financing (GlobeNewswire)
May-08-25 07:00AM	Evogene Schedules First Quarter 2025 Financial Results Release (PR Newswire)
Apr-22-25 09:24AM	Why Evogene Ltd. (EVGN) Soared on Monday (Insider Monkey) -11.81%
Apr-21-25 07:00AM	ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio (PR Newswire) +30.93%
Mar-06-25 07:15AM	Evogene Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
07:00AM	Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 (PR Newswire)
Feb-20-25 07:00AM	Evogene Schedules Fourth Quarter 2024 Financial Results Release (PR Newswire) -5.60%
Feb-13-25 08:00AM	AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease (PR Newswire)
Nov-21-24 07:30AM	Evogene Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-19-24 07:00AM	Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results (PR Newswire)
Nov-12-24 07:00AM	Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials (PR Newswire)
Nov-07-24 07:00AM	Evogene Schedules Third Quarter 2024 Financial Results Release (PR Newswire) -6.74%
Oct-31-24 08:00AM	Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design (PR Newswire) -5.00%
Oct-29-24 08:00AM	Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya (PR Newswire)
Oct-08-24 07:00AM	Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology (PR Newswire)
Sep-30-24 07:00AM	Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals (PR Newswire) +19.92%
Aug-23-24 08:55AM	Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement (PR Newswire) +9.30%
Aug-22-24 07:00AM	Evogene Reports Second Quarter 2024 Financial Results (PR Newswire) -10.80%
Aug-12-24 07:11AM	Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (PR Newswire) -6.74%
07:00AM	Evogene Schedules Second Quarter 2024 Financial Results Release (PR Newswire)
Jul-31-24 07:00AM	Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil (PR Newswire)
Jul-23-24 08:48AM	Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split (PR Newswire) -14.60%
Jul-17-24 08:00AM	ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants (PR Newswire)
Jul-02-24 07:00AM	Lavie Bio Announces Commercial Expansion of Yalos to Winter Wheat (PR Newswire)
Jun-25-24 07:00AM	Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country (PR Newswire)
May-30-24 08:02AM	Evogene Ltd. (NASDAQ:EVGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-23-24 11:52AM	EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
11:00AM	Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma (PR Newswire)
07:00AM	Evogene Reports First Quarter 2024 Financial Results (PR Newswire)
May-21-24 07:03AM	Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds (PR Newswire) +5.07%
May-09-24 07:00AM	Evogene Schedules First Quarter 2024 Financial Results Release (PR Newswire)
Apr-16-24 07:00AM	Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting (PR Newswire)
Apr-11-24 07:00AM	Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting (PR Newswire)
Apr-02-24 07:00AM	Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry (PR Newswire)
Mar-28-24 09:00AM	Evogene Announces Filing of Annual Report on Form 20-F (PR Newswire)
Mar-20-24 09:00AM	Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
Mar-19-24 09:00AM	Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing (PR Newswire)
Mar-13-24 09:00AM	Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America (PR Newswire) -5.84%
Mar-07-24 12:53PM	EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
09:20AM	Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Evogene Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Mar-06-24 07:00AM	AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides (PR Newswire)
Mar-05-24 07:00AM	Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties (PR Newswire)
Feb-28-24 07:00AM	Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements (PR Newswire)
Feb-26-24 07:00AM	Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 (PR Newswire)
Feb-22-24 07:00AM	AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer (PR Newswire)
Feb-21-24 07:00AM	AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution (PR Newswire) +22.03%
Feb-20-24 07:00AM	Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide (PR Newswire)
Feb-06-24 07:08AM	Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation (PR Newswire)
Jan-23-24 07:00AM	Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit (PR Newswire)
Jan-17-24 07:00AM	Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug (PR Newswire) -9.41%
Jan-12-24 12:00PM	Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy (Zacks)
Dec-21-23 07:00AM	Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024 (PR Newswire)
Dec-19-23 07:00AM	Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation (PR Newswire) +14.94%
Dec-05-23 07:00AM	Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos (PR Newswire) +15.19%
Nov-28-23 07:00AM	Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos, to Durum and Barley (PR Newswire) +5.72%
Nov-16-23 09:57AM	Evogene Ltd. (NASDAQ:EVGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-15-23 07:00AM	Evogene Reports Third Quarter 2023 Financial Results (PR Newswire)
Nov-08-23 07:00AM	Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results (PR Newswire)
Nov-02-23 07:00AM	Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023 (PR Newswire) +6.97%
Oct-31-23 07:00AM	Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology (PR Newswire)
Oct-18-23 07:00AM	Evogene Provides Operational Update Amidst Current Security Situation in Israel (PR Newswire) -6.04%
Sep-27-23 07:00AM	Casterra Delivers First Shipment of Castor Seeds to Africa (PR Newswire)
Aug-17-23 07:00AM	Evogene Reports Second Quarter 2023 Financial Results (PR Newswire) -19.16%
Aug-15-23 07:00AM	Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center (PR Newswire)
Aug-01-23 07:00AM	Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 (PR Newswire)
Jul-25-23 07:00AM	Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery (PR Newswire)
Jul-19-23 07:00AM	Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program (PR Newswire)
Jul-17-23 08:15AM	Evogene Announces Pricing of US$8,500,000 Registered Direct Offering (PR Newswire) -21.07%

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVGN

Evogene Ltd

Upgrade your Finviz experience